DNM1L and hepatocellular carcinoma: Despite the unsatisfactory efficacy of chemotherapy in the treatment of liver cell cancer, studies have demonstrated that inhibiting DNM1L-mediated mitochondrial fission can further promote apoptosis of liver carcinoma cells, thereby providing strong preclinical evidence for the development of mitochondrial autophagy-based combination therapies (Ma et al., 2020).